Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 18;30(9):1543-1551.
doi: 10.1093/jamia/ocad116.

Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China

Affiliations

Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China

Yao Yao et al. J Am Med Inform Assoc. .

Abstract

Background: Long-lasting nonpharmaceutical interventions (NPIs) suppressed the infection of COVID-19 but came at a substantial economic cost and the elevated risk of the outbreak of respiratory infectious diseases (RIDs) following the pandemic. Policymakers need data-driven evidence to guide the relaxation with adaptive NPIs that consider the risk of both COVID-19 and other RIDs outbreaks, as well as the available healthcare resources.

Methods: Combining the COVID-19 data of the sixth wave in Hong Kong between May 31, 2022 and August 28, 2022, 6-year epidemic data of other RIDs (2014-2019), and the healthcare resources data, we constructed compartment models to predict the epidemic curves of RIDs after the COVID-19-targeted NPIs. A deep reinforcement learning (DRL) model was developed to learn the optimal adaptive NPIs strategies to mitigate the outbreak of RIDs after COVID-19-targeted NPIs are lifted with minimal health and economic cost. The performance was validated by simulations of 1000 days starting August 29, 2022. We also extended the model to Beijing context.

Findings: Without any NPIs, Hong Kong experienced a major COVID-19 resurgence far exceeding the hospital bed capacity. Simulation results showed that the proposed DRL-based adaptive NPIs successfully suppressed the outbreak of COVID-19 and other RIDs to lower than capacity. DRL carefully controlled the epidemic curve to be close to the full capacity so that herd immunity can be reached in a relatively short period with minimal cost. DRL derived more stringent adaptive NPIs in Beijing.

Interpretation: DRL is a feasible method to identify the optimal adaptive NPIs that lead to minimal health and economic cost by facilitating gradual herd immunity of COVID-19 and mitigating the other RIDs outbreaks without overwhelming the hospitals. The insights can be extended to other countries/regions.

Keywords: Covid-19; artificial intelligence; infectious diseases; machine learning; mathematical modelling; reinforcement learning.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing interests.

Figures

Figure 1.
Figure 1.
The framework of the SEVQICR model. S, E, V, I, IC, Q, R, and D represent susceptible, exposed, vaccinated, infected, infected and traced as contacts, quarantined, recovered, and dead, respectively.
Figure 2.
Figure 2.
The demand for hospital beds without NPIs (Hong Kong).
Figure 3.
Figure 3.
The epidemic curves of RIDs and the corresponding NPIs derived by DRL (Hong Kong). Level 1 (closure of entertainment place), Level 2 (school closure, work from home, and no dine-in after 9 pm), Level 3 (no dine-in after 6 pm), Level 4 (maximum number of people gathering is 2), and Level 5 (regional lockdown).
Figure 4.
Figure 4.
The epidemic curves of RIDs and the corresponding NPIs derived by the threshold-based method with a threshold of 220 (Hong Kong). Level 1 (closure of entertainment place), Level 2 (school closure, work from home and no dine-in after 9 pm), Level 3 (no dine-in after 6 pm), Level 4 (maximum number of people gathering is 2), and Level 5 (regional lockdown).
Figure 5.
Figure 5.
The epidemic curves of RIDs and the corresponding NPIs derived by RL (Hong Kong). Level 1 (closure of entertainment place), Level 2 (school closure, work from home, and no dine-in after 9 pm), Level 3 (no dine-in after 6 pm), Level 4 (maximum number of people gathering is 2), and Level 5 (regional lockdown).
Figure 6.
Figure 6.
The demand for hospital beds without NPIs (Beijing).
Figure 7.
Figure 7.
The epidemic curves of RIDS and the corresponding NPIs derived by DRL (Beijing without temporary mobile field hospitals). Level 1 (closure of entertainment place), Level 2 (school closure, work from home, and no dine-in after 9 pm), Level 3 (no dine-in after 6 pm), Level 4 (maximum number of people gathering is 2), and Level 5 (regional lockdown).
Figure 8.
Figure 8.
The epidemic curves of RIDS and the corresponding NPIs derived by DRL (Beijing with temporary mobile field hospitals). Level 1 (closure of entertainment place), Level 2 (school closure, work from home, and no dine-in after 9 pm), Level 3 (no dine-in after 6 pm), Level 4 (maximum number of people gathering is 2), and Level 5 (regional lockdown).

Similar articles

Cited by

References

    1. Xiao J, Dai J, Hu J, et al. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study. Lancet Reg Health West Pac 2021; 17: 100282. - PMC - PubMed
    1. Walker PG, Whittaker C, Watson OJ, et al. The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries. Science 2020; 369 (6502): 413–22. - PMC - PubMed
    1. Müller O, Razum O, Jahn A. Effects of non-pharmaceutical interventions against COVID-19 on the incidence of other diseases. Lancet Reg Health Eur 2021; 6: 100139. - PMC - PubMed
    1. Lai S, Ruktanonchai NW, Zhou L, et al. Effect of non-pharmaceutical interventions to contain COVID-19 in China. Nature 2020; 585 (7825): 410–3. - PMC - PubMed
    1. Mok CKP, Cohen CA, Cheng SMS, et al. Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong. Respirology 2022; 27 (4): 301–10. - PMC - PubMed

Publication types